NextPlat Corp. (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions, reported third-quarter 2026 revenue of approximately $10.5 million, compared with $13.8 million in the prior-year period. The decline reflects lower pharmacy reimbursement rates and retail prescription volumes. Despite the revenue drop, gross margin improved significantly to approximately 35% from 19.9%, while net loss attributable to common stockholders narrowed 66% to approximately $700,000, or $0.28 per diluted share, from $2.2 million, or $0.84 per diluted share.
The margin expansion and loss reduction underscore a strategic shift toward higher-margin services. Pharmacy contract revenue increased 300% to approximately $2.4 million, driven by growth in higher-margin 340B services, while e-commerce revenue rose 3% to approximately $3.8 million. The company ended the quarter with approximately $11.2 million in cash and $13.5 million in working capital, with no material unsecured debt. NextPlat continued expanding its healthcare operations through the acquisition of Scott’s Pharmacy near Pensacola, Florida, and the opening of a new Jacksonville location. The company also plans to launch a nationwide medication fulfillment website in the fourth quarter, providing consumers across all 50 states with online access to prescription and over-the-counter healthcare products. Management expects contributions from its expanded pharmacy network and new contracted services to support future growth.
For investors, the results signal improving profitability despite top-line pressure, as the company shifts its mix toward higher-margin businesses. The 340B program, which allows eligible healthcare organizations to purchase outpatient drugs at reduced prices, has been a key growth driver. NextPlat’s ability to scale this segment while expanding its retail pharmacy footprint could position it for sustained margin gains. The upcoming nationwide fulfillment website represents a significant expansion of its direct-to-consumer reach, potentially unlocking new revenue streams. However, the revenue decline highlights ongoing challenges in the pharmacy sector, including reimbursement rate pressures. The company’s strong cash position and working capital provide flexibility to fund growth initiatives.
To view the full press release, visit https://ibn.fm/8alUs. The latest news and updates relating to NXPL are available in the company’s newsroom at https://ibn.fm/NXPL. This press release was distributed by InvestorWire, a specialized communications platform and one of 75+ brands within the Dynamic Brand Portfolio @ IBN. InvestorWire provides access to a vast network of wire solutions, including editorial syndication to 5,000+ outlets and social media distribution to millions of followers. For more information, please see the full terms of use and disclaimers at https://www.InvestorWire.com/Disclaimer.
